Target intelligence / Profile preview

Nitric oxide synthase 2 pseudogene 4 (NOS2P4)

Target: NOS2P4
Molecular classification: Other (Pseudogene)

Overview

Nitric oxide synthase 2 pseudogene 4 (NOS2P4) is classified as a pseudogene, meaning it is a nonfunctional segment of DNA that resembles a gene but typically does not produce a functional protein. Pseudogenes like NOS2P4 may arise from gene duplication or retrotransposition events and often lack the capability for protein expression due to mutations or incomplete gene structure. Unlike the functional gene NOS2 (which encodes inducible nitric oxide synthase, a key enzyme in nitric oxide production and immune response), NOS2P4 does not contribute to biological function or known disease mechanisms and has no direct therapeutic relevance.

Other names: Nitric oxide synthase 2, inducible pseudogeneNOS2P4

Beyond the preview

Go deeper on Nitric oxide synthase 2 pseudogene 4 (NOS2P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nitric oxide synthase 2 pseudogene 4 (NOS2P4).

Explore the full profile